Plain-English translation of NCT06751030 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing whether a home-based cervical cancer screening program can reach more women living with HIV in Nigeria. Researchers are adapting an existing peer-support program called MoMent to include HPV (human papillomavirus) screening that women can do at home, followed by simple in-clinic follow-up tests if needed. The goal is to make cervical cancer screening easier to access and more acceptable to women living with HIV.
Women living with HIV have a much higher risk of cervical cancer, but many in Nigeria don't get screened because clinics are hard to reach or stigma makes them uncomfortable seeking care. This trial exists to test whether bringing screening into homes—with help from peer mentors—can get more women the early detection and treatment they need.
You likely qualify if…
You likely don't qualify if…
You would receive a home-based HPV screening kit and instructions from a peer mentor called a 'Mentor Mother,' who will also help you schedule any follow-up visits. If your home screening test is negative, you'll return for retesting one year later. If your test is positive, you'll attend a clinic visit for a visual inspection test; depending on the results, you may need treatment (such as thermal ablation) and repeat testing over one to two years. A peer mentor and clinical staff will support you throughout the process.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
Nigeria